IP Verse

High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use Thereof

Patent No. EP4121007 (titled "High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use Thereof") was filed by Eisai R&D Management on Mar 19, 2021. The application was issued on Jul 2, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFFApr 1, 2026SONNENHAUSER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4121007

EISAI R&D MANAGEMENT
Application Number
EP21722538A
Filing Date
Mar 19, 2021
Status
Granted And Under Opposition
May 29, 2025
Publication Date
Jul 2, 2025
External Links
Slate, Register , Google Patents